Company page
Biogen Inc.
Biogen Inc. is a public company traded under the ticker BIIB in the American market. With a market capitalization of approximately $29.02 billion, Biogen focuses on developing therapies for neurological diseases. The company is known for its commitment to innovation in the biotechnology sector.
- Ticker
- BIIB:NASDAQ
- Asset type
- Stock
- Market cap
- $29.02B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD